Supriya Lifescience has received approval from the Bombay High Court for the provisional release of a 200 kg Ketamine Hydrochloride consignment. The relief is conditional upon the company depositing Rs 72 lakh with Customs authorities within one week. While the order clears the way for inventory recovery, the court noted that underlying adjudication and criminal proceedings against the company will continue, keeping the legal matter active.
Supriya Lifescience Gets Court Nod for Provisional Consignment Release
Consignment release approved for 200 kg of Ketamine; Rs 72 lakh deposit ordered by Bombay High Court.
Reader Takeaway: Provisional inventory access is granted, but ongoing legal and criminal adjudication proceedings remain a material uncertainty.
What just happened
The Hon'ble High Court of Bombay has passed an order allowing Supriya Lifescience Ltd to provisionally release a 200 kg consignment of Ketamine Hydrochloride, which was subject to a shipping dispute. The court has mandated the company to deposit Rs 72 lakh with the Assistant Commissioner of Customs, Export, ACC, Mumbai-III. This payment must be facilitated within one week from the September 22, 2026, order date.
Why this matters
For investors, the immediate release of the consignment allows the company to manage its inventory and reduces the risk of spoilage or complete loss of the subject goods. However, the court has explicitly maintained the status quo regarding the legality of the shipment. By clarifying that adjudication and criminal proceedings will continue as per the law, the court has signaled that the core regulatory challenge facing the company remains open.
What changes now
Supriya Lifescience must now complete the financial deposit to meet the compliance deadline. Failure to deposit the Rs 72 lakh within the seven-day window could jeopardize the provisional release. The company is now expected to cooperate with Customs authorities as they proceed with the adjudication process.
Risks to watch
Investors should closely track the progression of the ongoing criminal proceedings. The court also noted that concerned officers are free to follow procedures under Section 52A of the NDPS Act, which governs the disposal of seized narcotic drugs and psychotropic substances. Any escalation in the regulatory stance or adverse findings in the adjudication process could lead to further financial or operational hurdles.
What to track next
Shareholders should monitor future BSE filings for any communication regarding the completion of the deposit and updates on the status of the adjudication proceedings. Any further notices from Customs or the court regarding the final outcome of the investigation will be critical for assessing the long-term impact on the company's compliance framework.